▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #98 by analyst upside · 2026-06-27
AEON
AEON Biopharma, Inc.
Healthcare · Market Cap $19M · P/E 0x
ANALYST PRICE TARGET
+828.0%
implied upside to consensus target
Current Price $0.72
Consensus Target $6.7
Bull Target $8.4
Bear Target $5.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $0.51
52-Week High $1.45
YTD Return -35.0%
FUNDAMENTALS
Market Cap $19M
P/E Ratio (TTM) N/A
Forward P/E -1.0x
EPS (TTM) $-6.82
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.51
52-Week High $1.45
Current Price $0.72
Bear Target $5.0
Bull Target $8.4
● Now $0.72 ● Target $6.7
TRADING DATA
Avg Volume 86K
YTD Return -35.0%
Analyst Count 2
Consensus Buy
Upside to Target +828.0%
Last Updated 2026-06-27

ANALYST SUMMARY

AEON Biopharma, Inc. (AEON) is currently trading at $0.72 with a Wall Street consensus price target of $6.7, implying potential upside of 828.0% over the next 12 months. 2 analysts currently cover AEON, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.4, while the most cautious has a target of $5.0.

AEON operates in the Healthcare sector with a market capitalisation of $19M. The stock is down 35.0% year-to-date and is currently trading near the lower end of its 52-week range of $0.51 – $1.45.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PSTV +757.1%
Plus Therapeutics, Inc.
$29M · P/E 0.2x · Buy
DWTX +748.5%
Dogwood Therapeutics, Inc.
$55M · P/E 1.4x · Strong Buy
ETST +566.7%
Earth Science Tech, Inc.
$43M · P/E 15.0x · Hold
VXRT +488.2%
Vaxart, Inc.
$123M · P/E 3.2x · Buy
AGEN +411.6%
Agenus Inc.
$126M · P/E 1.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AEON, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Aegis Capital reit
Buy → Buy 2025-10-08 Building track record
HC Wainwright & Co. reit
Buy → Buy 2024-10-01 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2024-08-14 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-07-10 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →